
Enlivex
5 Watchlists
Treasury
Status
What is Enlivex?
Enlivex is a publicly traded company (Nasdaq: ENLV) operating with two distinct but connected components. The first is its clinical-stage immunotherapy asset, Allocetra™, which targets age-related knee osteoarthritis. The therapy is designed to reprogram macrophages—immune cells involved in inflammation—with the goal of restoring mobility and function in aging populations. Phase II clinical data reported a 72% reduction in pain and a 109% improvement in function across more than 250 treated patients.
The second component is a treasury model. Rather than holding cash or passive token reserves, Enlivex anchors its treasury in Rain, a decentralized prediction markets protocol on Arbitrum. The company’s treasury exposure is tied to Rain protocol activity, with a fee-linked buyback mechanism connected to network usage. This structure is intended to create a link between the company’s financial reserves and the economic activity of the prediction markets infrastructure, while reducing reliance on repeated equity dilution for capital.
Trending Coins and Tokens 

Prime Intellect

Gauntlet

01.xyz

Elliptic
- 218

Tagger
TAG
$ 0.0009749
43.1% 
KOR Protocol
- 445

Ankr Network
ANKR
$ 0.0036
1.60%